@article {2020, title = {Analysis Factors Affecting the Utilization of Antiretroviral Treatment Services in HIV Patients in Ambon City Puskesmas}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {April 2023}, pages = {424-428}, type = {Research Article}, chapter = {424}, abstract = {

Acquired Immune Deficiency Syndrome (AIDS) is a collection of symptoms that arise due to decreased immunity caused by HIV infection. Human Immunodeficiency Virus (HIV) is a type of virus that infects white blood cells which causes a decrease in human immunity. Efforts are being made at this time for people with HIV namely Antiretroviral treatment (ARV). This study aims to analyze the factors that influence the utilization of ARV treatment services in HIV patients at the Ambon City Health Center. This type of research is a quantitative analytic study with a cross sectional design. Respondents in this study were obtained using the Isaac and Michael method of 156 HIV patients from the Waihaong Health Center and Karpan Health Center in Ambon City using a questionnaire. Data processing was carried out using SPSS and for data analysis using statistical tests using descriptive statistical tests, comparative analysis tests and multivariate analysis tests. The results showed that there was no effect of knowledge on the use of ARV treatment in HIV patients at the Ambon City Health Center. Furthermore, there is an influence on the patient{\textquoteright}s actions, access distance, and peer and community support on the use of ARV treatment in HIV patients at the Ambon City Health Center. The action variable and access distance are the variables that have the strongest influence compared to the other variables.

}, keywords = {AIDS, ARV, HIV, Puskesmas, Utilization}, doi = {10.5530/pj.2023.15.66}, author = {Faradila Kilkoda and Balqis and Indar and Darmawansyah and Atjo Wahyu and Anwar Daud and Anwar Mallongi} } @article {996, title = {In silico Analysis of Flavonoid Glycosides and its Aglycones as Reverse Transcriptase Inhibitor}, journal = {Pharmacognosy Journal}, volume = {11}, year = {2019}, month = {October 2019}, pages = {1252-1255}, type = {Original Article}, chapter = {1252}, abstract = {

Background: HIV continues to be a major global public health issue, having claimed more than 35 million lives so far. In 2016, 1 million people died from HIV-related causes globally. HIV-1 reverse transcriptase is one of HIV{\textquoteright}s vital enzymes for virus reproduction. If the enzyme is inhibited, the virus multiplication could be significantly decreased. There are currently many treatments for HIV, but more effective treatment is always needed because of the possibility of drug resistance and side effects for long-term use. Based on the previous study, there are some natural compounds with high affinity to the HIV-1 reverse transcriptase enzyme. Some of these compounds are flavonoid glycosides. Aims and Method: This study was aimed to learn more about in silico HIV-1 reverse transcriptase inhibitory activities of flavonoid glycosides using docking method. Results: The results showed that the most recommended flavonoid glycosides are those with the lowest binding energy, which were kaempferol-3-O-rhamnoside, myricetin-3-O-rhamnoside and quercetin-3-O-rhamnoside. This was due to the interactions of all three flavonoid rings and sugar moiety with key amino acid residues, which were Leu100, Lys101, Glu138, Tyr181, His235 and Tyr318. Conclusion: Flavonoid glycosides with rhamnose as glycone showed lower binding energy on HIV-1 reverse transcriptase.

}, keywords = {Flavonoid, Glycosides, HIV, Molecular docking, Reverse transcriptase}, doi = {10.5530/pj.2019.11.194}, author = {Stefandi J Wijaya and Arry Yanuar and Rosita Handayani and Rezi Riadhi Syahdi} }